After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the ...
Most recently, Amgen faced the kind of legal challenges normally reserved for big pharma, with allegations of allegedly violating anti-kickback rules by “overfilling” Aranesp vials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback